Catalyst Wire Dossier Catalyst Wire Dossier

Kisqali (ribociclib)

ribociclib · Novartis
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Kisqali (ribociclib), covering 2024-04-05 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME) [NA]

See pricing